series-c-plus
Stage
2
Investors
About
Nanologica develops and manufactures advanced silica-based chromatography media for the purification of pharmaceutical substances, focusing on peptide drugs, and offers contract manufacturing services through its subsidiary Syntagon.
Explore Nanologica's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.